lepirudiin - Resultados da pesquisa

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

epirubicin actavis epirubicin hydrochloride 50 mg powder for injection vial

medis pharma pty ltd - epirubicin hydrochloride, quantity: 50 mg - injection, powder for - excipient ingredients: methyl hydroxybenzoate; lactose monohydrate - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small-cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/metastatic soft tissue sarcoma and superficial bladder cancer (tis, ta). in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

Austrália - inglês - Department of Health (Therapeutic Goods Administration)

epirubicin actavis epirubicin hydrochloride 10 mg powder for injection vial

medis pharma pty ltd - epirubicin hydrochloride, quantity: 10 mg - injection, powder for - excipient ingredients: lactose monohydrate; methyl hydroxybenzoate - epirubicin hydrochloride has produced responses in a wide spectrum of neoplastic diseases, and is indicated for the treatment of breast cancer, gastric cancer, ovarian cancer, small-cell lung cancer, lymphoma (non-hodgkin's lymphoma), advanced/metastatic soft tissue sarcoma and superficial bladder cancer (tis, ta). in bladder cancer, epirubicin hydrochloride is also indicated in the prophylaxis of recurrence after transurethral resection of stage t1 papillary cancers and stage ta multifocal papillary cancers (grade 2 and 3).

Nova Zelândia - inglês - Medsafe (Medicines Safety Authority)

epirubicin

rex medical ltd - epirubicin hydrochloride 2 mg/ml; - solution for injection - 2 mg/ml - active: epirubicin hydrochloride 2 mg/ml excipient: hydrochloric acid sodium chloride water for injection - epirubicin has produced significant therapeutic responses in a number of neoplastic diseases, among which: carcinoma of the breast.